What Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund bought and sold in September 2026
This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of Edelweiss Mutual Fund.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
| Sun Pharmaceutical Industries Ltd. | Reduced | −0.2% | 10.45% |
|---|---|---|---|
| Divi's Laboratories Ltd. | Reduced | −0.2% | 7.09% |
| ELI LILLY & CO | Reduced | −2.7% | 6.46% |
| Apollo Hospitals Enterprise Ltd. | Reduced | −0.2% | 5.25% |
| Max Healthcare Institute Ltd. | Reduced | −0.2% | 4.19% |
| Torrent Pharmaceuticals Ltd. | Reduced | −0.2% | 4.38% |
| JOHNSON & JOHNSON | Reduced | −2.4% | 4.45% |
| Laurus Labs Ltd. | Reduced | −0.1% | 4.44% |
| Cipla Ltd. | Reduced | −0.2% | 4.34% |
| Dr. Reddy's Laboratories Ltd. | Reduced | −0.2% | 3.95% |
| ABBVIE INC | Reduced | −2.5% | 3.22% |
| Lupin Ltd. | Reduced | −0.2% | 2.97% |
| Aurobindo Pharma Ltd. | Reduced | −1.1% | 2.77% |
| Fortis Healthcare Ltd. | Reduced | −0.2% | 2.41% |
| MERCK & CO.INC | Reduced | −2.5% | 2.50% |
| Glenmark Pharmaceuticals Ltd. | Reduced | −0.2% | 2.11% |
| NOVARTIS AG | Reduced | −2.4% | 1.82% |
| THERMO FISHER SCIENTIFIC INC | Reduced | −2.5% | 1.75% |
| IPCA Laboratories Ltd. | Reduced | −0.2% | 1.72% |
| Mankind Pharma Ltd. | Reduced | −0.1% | 1.65% |
| Biocon Ltd. | Reduced | −4.1% | 1.47% |
| AMGEN INC | Reduced | −2.3% | 1.59% |
| Alkem Laboratories Ltd. | Reduced | −0.2% | 1.38% |
| Zydus Lifesciences Ltd. | Reduced | −1.0% | 1.37% |
| Gland Pharma Ltd. | Reduced | −0.1% | 1.37% |
| ABBOTT LABORATORIES | Reduced | −2.3% | 1.20% |
| GILEAD SCIENCES INC | Reduced | −2.3% | 1.29% |
| Aster DM Quality Care Ltd. | Reduced | −0.2% | 1.04% |
| Ajanta Pharma Ltd. | Reduced | −0.2% | 1.01% |
| INTUITIVE SURGICAL INC | Reduced | −2.6% | 1.00% |
| Novo Nordisk A/S | Reduced | −2.4% | 0.85% |
| DANAHER CORP | Reduced | −2.4% | 0.98% |
| VERTEX PHARMACEUTICALS INC | Reduced | −2.5% | 0.93% |
| MEDTRONIC PLC | Reduced | −2.6% | 0.77% |
| STRYKER CORP | Reduced | −2.2% | 0.66% |
| Global Health Ltd. | Reduced | −0.1% | 0.70% |
| GlaxoSmithKline Pharmaceuticals Ltd. | Reduced | −0.2% | 0.67% |
| Narayana Hrudayalaya ltd. | Reduced | −0.2% | 0.70% |
| Wockhardt Ltd. | New | New | 0.62% |
| Regeneron Pharmaceuticals Inc | Reduced | −2.7% | 0.55% |
| Anthem Biosciences Ltd. | Added | +14.1% | 0.55% |
| BECTON DICKINSON AND CO | Reduced | −5.7% | 0.34% |
| AGILENT TECHNOLOGIES INC | Reduced | −2.5% | 0.34% |
| IQVIA HOLDINGS INC | Reduced | −3.7% | 0.31% |
| WATERS CORP | Reduced | −2.1% | 0.30% |
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Frequently Asked Questions
Which new stocks did Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund buy in September 2026?
It bought 1 new stock: Wockhardt Ltd (0.62%). Each figure is the stock's share of the fund at the end of September 2026.
Which stocks did Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund sell completely in September 2026?
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund did not sell any stock completely in September 2026.
Which stocks did Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund buy more of in September 2026?
The largest increases in shares held were Anthem Biosciences Ltd (+14.1%).
Which stocks did Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund sell part of in September 2026?
The largest cuts in shares held were BECTON DICKINSON AND CO (−5.7%), Biocon Ltd (−4.1%), IQVIA HOLDINGS INC (−3.7%), ELI LILLY & CO (−2.7%) and Regeneron Pharmaceuticals Inc (−2.7%). It reduced 38 more.
How are these changes worked out?
WealthGamma compares the number of shares Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of Edelweiss Mutual Fund. A change in share price alone does not count as buying or selling.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.